the aid library

LIST OPTIONS

Filter

2563

Sort by:

Direction:

Download (1382)

View PDF (4012)

Nutritional care of children and adults with Ebola virus disease in treatment centres

World Health Organization; UNICEF; World Food Programme (2014)

. Interim Guidelines. This interim guideline lays out some basic principles of optimal nutritional care for adults and paediatric patients during treatment and convalescence in Ebola treatment units, community care centres or to other centres where Ebola patients are receiving care and support. It h... more

Download (160)

View PDF (205)

Behavorial Health Departement - Primary Care Center and fireweed Treatment Guidelines for PTSD

Sorkin, J., Chaney, G., Garcia, M.,et al. (2006) C2

This treatment guideline is intended to assist clinicians in the Behavioral Health department in treatment planning and service delivery for patients with Post Traumatic Stress Disorder (PTSD). It may also assist clinicians treating patients who have some of the signs and symptoms of PTSD but who do... more

Download (116)

View PDF (208)

Bipolar disorder: assessment and management

National Institute for Health and Care Excellence (NICE) (2014) CC

Clinical Guideline

Download (199)

View PDF (236)

Diagnosis and management of epilepsy in adults

Healthcare Improvement Scotland Scottish Intercollegiate Guideline Network (2018) C1

SIGN 143. A national clinical guideline Published May 2015, Revised 2018

Download (263)

View PDF (266)

Social Anxiety Disorder

National Institute for Health and Care Excellence (NICE) (2013) C2

Recognition, Assessment and Treatment National Clinical Guideline Number 159

Download (948)

View PDF (1301)

Screening, assessment and management of neonates and infants with complications associated with Zika virus exposure in utero

World Health Organization WHO (2016) C_WHO

This Rapid Advice Guideline updates the Interim Guidance on the “Assessment of infants with microcephaly in the context of Zika virus” published in February 2016 (WHO/ZIKV/MOC/16.3). The recommendations provides guidance on the screening, clinical assessment, neuroimaging, laboratory investigati... more

Download (211)

View PDF (376)

Optimized Supportive Care for Ebola Virus Disease
recommended

World Health Organization WHO (2019) C_WHO

Clinical management standard operating procedures. Ebola virus disease (EVD) is a life-threatening multisystem illness associated with fever and gastrointestinal (GI) symptoms that frequently leads to hypovolaemia, metabolic acidosis, hypoglycaemia, and multi-organ failure. The prolonged 2013–201... more

Download (260)

View PDF (448)

Epilepsies: diagnosis and management
recommended

National Institute for Health and Care Excellence (NICE) (2012) C2

Clinical guideline | Published: 11 January 2012 | nice.org.uk/guidance/cg137

Download (905)

View PDF (1271)

WHO recommendations: intrapartum care for a positive childbirth experience

World Health Organization WHO (2018) C_WHO

The recommendations in this guideline are intended to inform the development of relevant national- and local-level health policies and clinical protocols. Therefore, the target audience includes national and local public health policy-makers, implementers and managers of maternal and child health pr... more

Download (621)

View PDF (2918)

Hepatitis B (chronic): Diagnosis and management of chronic hepatitis B in children, young people and adults

Aftab Ala, Elizabeth Boxall, Steven Bradley et al. National Clinical Guideline Centre (2013)

Clinical guideline, Methods, Evidence and Recommendations In this guideline the following is covered: information needs of people with chronic hep titis B and their carers; where children, young people and adults with chronic hepatitis B a- should be assessed; assessment of liver disease, includi... more

Download (58)

View PDF (712)

Guideline focus: COVID-19 rapid guideline on critical care (NICE)

BMJ Learning (2020) CC

This module takes you through the NICE coronavirus disease (COVID-19) rapid guideline: critical care in adults, providing resources to support their recommendations and patient scenarios to demonstrate key learning points. Learning outcomes After completing this module you should understand: ... more

Download (84)

View PDF (122)

Guidelines for Critical Care of Seriously Ill Adult Patients with Coronavirus (COVID-19) in the Americas
recommended

Pan American Health Organisation PAHO (2020) C_WHO

Short Version This clinical practice guideline was developed in order to provide recommendations for the management of critically ill adult patients with COVID-19 in intensive care units (ICUs).

Download (57)

View PDF (549)

COVID-19 review of national clinical practice guidelines for key questions relating to the care of pregnant women and their babies

Cochrane Pregnancy and Childbirth (2020)

Many clinicians and pregnant women with their families are facing similar questions about the care and wellbeing of women and their babies with confirmed or suspected Covid-19. Cochrane believe it is important to identify, collate and summarise national clinical practice guideline recommendations ... more

Download (96)

View PDF (148)

Practice Education in Nursing

Registered Nurses’ Association of Ontario (RNAO) (2016) CC

The purpose of this Guideline is to provide evidence-based recommendations that promote and sustain the undergraduate nursing student’s application of knowledge to practice in a variety of clinical learning environments. The Guideline explores the relationships among and between students and nursi... more

Download (429)

View PDF (228)

WHO recommendations for care of the preterm or low-birth-weight infant
recommended

World Health Organization WHO (2022) C_WHO

The recommendations in this guideline are intended to inform development of national and subnational health policies, clinical protocols and programmatic guides. The target audience includes national and subnational public health policy-makers, implementers and managers of maternal, newborn and chil... more

Download (137)

View PDF (163)

Drugs to prevent COVID-19: living guideline

World Health Organisation (WHO) (2023) C_WHO

The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform. Guidelines ... more

Download (247)

View PDF (203)

Infection prevention and control guideline for Ebola and Marburg disease, August 2023
recommended

World Health Organization WHO (2023) CC

Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected. Infection prevention and control (IP... more

Download (240)

View PDF (323)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (14)

View PDF (12)

South American guidelines for cardiovascular disease prevention and rehabilitation

Herdy, A.H.; López-Jiménez, F.; Terzic, C.P. et al. Arquivos Brasileiros de Cardiologia (2014) CC

In this document, the Inter-American Committee of Cardiovascular Prevention and Rehabilitation, together with the South American Society of Cardiology, aimed to formulate strategies, measures, and actions for cardiovascular disease prevention and rehabilitation (CVDPR). In the context of the imple... more

External Link (64)

Google Scholar (83)

WorldCat (63)

European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5–16 years

Gaillard, E.A.; Kuehni, C.E.; Turner, S.; et al. European Respiratory Journal (2021) CC

Diagnosing asthma in children represents an important clinical challenge. There is no single gold-standard test to confirm the diagnosis. Consequently, over- and under-diagnosis of asthma is frequent in children. A task force supported by the European Respiratory Society has developed these evidence... more

Optimized Supportive Care for Ebola Virus Disease recommended

Epilepsies: diagnosis and management recommended

Guidelines for Critical Care of Seriously Ill Adult Patients with Coronavirus (COVID-19) in the Americas recommended

WHO recommendations for care of the preterm or low-birth-weight infant recommended

Infection prevention and control guideline for Ebola and Marburg disease, August 2023 recommended

Optimized Supportive Care for Ebola Virus Disease
recommended

Epilepsies: diagnosis and management
recommended

Guidelines for Critical Care of Seriously Ill Adult Patients with Coronavirus (COVID-19) in the Americas
recommended

WHO recommendations for care of the preterm or low-birth-weight infant
recommended

Infection prevention and control guideline for Ebola and Marburg disease, August 2023
recommended